Virus cocktail takes on superbug UTIs in new trial
NCT ID NCT07382271
First seen Feb 02, 2026 · Last updated May 15, 2026 · Updated 12 times
Summary
This early study tests a virus-based treatment (phage therapy) in 6 adults aged 18–65 with drug-resistant urinary tract infections. Participants receive the phage cocktail for 2–3 days and are followed for up to 4 weeks. The goal is to see if it safely clears the infection and improves symptoms like fever and pain.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for URINARY TRACT INFECTIONS are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.